CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 152 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $31,045,127 | +2453.4% | 808,046 | +1438.5% | 0.01% | +1200.0% |
Q1 2023 | $1,215,838 | -11.6% | 52,520 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,376,024 | +99.4% | 52,520 | +49.5% | 0.00% | – |
Q3 2022 | $690,000 | +12.4% | 35,120 | 0.0% | 0.00% | – |
Q2 2022 | $614,000 | +11.0% | 35,120 | +3.8% | 0.00% | – |
Q1 2022 | $553,000 | +0.5% | 33,820 | +0.3% | 0.00% | – |
Q4 2021 | $550,000 | +36.5% | 33,720 | +6.6% | 0.00% | – |
Q3 2021 | $403,000 | -9.6% | 31,620 | 0.0% | 0.00% | – |
Q2 2021 | $446,000 | +18.6% | 31,620 | +30.6% | 0.00% | – |
Q1 2021 | $376,000 | -2.1% | 24,220 | 0.0% | 0.00% | – |
Q4 2020 | $384,000 | – | 24,220 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 5 | $0 | 0.00% |